Teva Pharmaceutical Industries Limited TEVA reported fourth-quarter 2018 earnings of 53 cents per share, which missed the Zacks Consensus Estimate of 56 cents per share. Earnings per share declined 43% year over year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,